61 min listen
Joel Rurik: CAR-T Therapies to Reverse Cardiac Fibrosis
Joel Rurik: CAR-T Therapies to Reverse Cardiac Fibrosis
ratings:
Length:
36 minutes
Released:
Jul 9, 2022
Format:
Podcast episode
Description
Injury to organs frequently results in impaired function due to the formation of scar tissue. Heart attacks and chronic high blood pressure can induce the formation of pathogenic fibroblasts, cells that lose their original function, yet maintain some structural element of the injured tissue. The formation of fibrogenic tissue affects a significant portion of the population, and contributes to decline associated with many diseases, such as congestive heart failure or liver cirrhosis. A new technology uses targeted lipid nanoparticles to reprogram T-cells to attack pathogenic fibroblasts.
Released:
Jul 9, 2022
Format:
Podcast episode
Titles in the series (100)
Biotechnology in Uganda; Reflections on a Public Discussion: This week features two discussions with fellows serving in the Global Leadership Program of the Cornell Alliance for Science. The first part is a discussion with Nassib Mugwanya, Outreach Leader for the Ugandan Biosciences Information Center. He discuss by Talking Biotech with Dr. Kevin Folta